ISV President’s Message

Linda S. Klavinskis, PhD (ISV President, 2024-2025)
Professor of Viral Immunology, Department of Infectious Diseases, King’s College London.

It is an honour and privilege to serve as President of the ISV, an association that brings together talented scientists from across the globe at all stages of their careers to exchange knowledge, sparks new ideas and inspires solutions to the most challenging human, animal, and One Health problems amenable to vaccine and immunotherapeutic interventions.

I would like to thank Dr Denise Doolan, the outgoing ISV President for her leadership during her term and congratulate Ted Gibson on assuming the position of Director of ISV Operations.  Read more…

ISV Members:

Join us today:

ISV’s Upcoming Events

NextGen November Webinar

November 13

2026 ISV Annual Congress

October 12, 2026 - October 14, 2026

Visit HERE

ISV’s News & Insights

ISV 2025 Annual Congress Highlights

2025 ISV Annual Congress

ISV 2025Annual Congress Awards
Bright Sparks and Posters

Congratulations!

Bright Sparks in Vaccinology – PhD Oral Presenter Session  

1st – Jack Saunders, University of Oxford, United Kingdom

2nd – Dylan Kairuz, University of the Witwatersrand, South Africa

3rd – Arturo Linan-Torres, National Autonomous University of Mexico, Mexico

Bright Sparks in Vaccinology – ECR Oral Presenter Session  

1st - Nicholas Tursi, The Wistar Institute, USA

2nd – Juan Garcia-Bernalt Diego, Centro de investigación Hospital Universitario 12 de Octubre, Spain

3rd – Claire Otero, Weill Cornell Medicine, USA

Poster Presenter PhD Category 

1st – Raphael Kamng’ona, MRC Unit at LSHTM

2nd – Chinedu Anthony Iwu, IMO STATE UNIVERSITY/TEACHING HOSPITAL

Joint 3rd – Giovanna de Brito Carneiro, Instituto Butantan

Joint 3rd – Nelisa Makeleni, University of Cape Town

Joint 3rd – Rhoda Namakula, University of Bergen

Joint 3rd – Natalie Nel, University of Cape Town

Poster Presenter ECR Category 

1st - Faiaz Shaik Abdool,Africa Health Research Institute

2nd – Trésor Zola Matuvanga, Université de Kinshasa

Joint 3rd – Christine Bulaon, Baiya Phytopharm Co., Ltd.

Joint 3rd – Henning Jacobsen, Helmholtz Centre for Infection Research

About ISV

ISV 2025 Annual Congress

2025 ISV Virtual Congress

ISV Events

Mentorship Programme

Next Generation Vaccinologists

ISV Membership

Donors

Sponsors

Career

ISV Newsletter

ISV Annual Supporters

Partners

Gold

Silver

Other

2025 ISV Annual Congress Exhibitors

The International Society for Vaccines is an organization that engages, supports, and sustains the professional goals of a diverse membership in all areas relevant to vaccines and immunotherapeutics.  The ISV is a global not-for-profit organization that aims to encourage, establish, and promote the development and use of vaccines to prevent and control infectious and non-infectious diseases in animals and humans.
info@isv-online.org  /  ISV Annual Congress
LinkedIn
Facebook
YouTube